Skip to main content

Transgenomic Shares Slide 5 Percent on News of CEO Departure

NEW YORK, April 4 (GenomeWeb News) - Shares of Transgenomic were down 5.63 percent, or $.04, at $.67 in mid-afternoon trading after the company said CEO Collin D'Silva has resigned.

 

As GenomeWeb News reported this morning, Michael Summers, the company's chief financial officer, has taken over as interim CEO until a new chief executive has been found. He also remains CFO.

 

D'Silva will remain chairman of the board and will manage "strategic customer relationships" and evaluate corporate strategic alternatives.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.